Singapore markets closed

JW (Cayman) Therapeutics Co. Ltd (2126.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.550+0.090 (+3.66%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
173,856
173,856
145,702
30,797
0
Cost of revenue
85,637
85,637
86,946
21,752
0
Gross profit
88,219
88,219
58,756
9,045
0
Operating expenses
Research development
413,616
413,616
407,818
414,397
225,215
Selling general and administrative
117,751
117,751
160,350
249,979
93,142
Total operating expenses
658,611
658,611
755,078
780,203
468,455
Operating income or loss
-570,392
-570,392
-696,322
-771,158
-468,455
Interest expense
12,415
12,415
6,787
2,692
770
Income before tax
-767,996
-767,996
-846,135
-702,328
-1,663,803
Income tax expense
0
0
0
0
0
Income from continuing operations
-767,996
-767,996
-846,135
-702,328
-1,663,803
Net income
-767,996
-767,996
-846,135
-702,328
-1,663,803
Net income available to common shareholders
-767,996
-767,996
-846,135
-702,328
-1,663,803
Basic EPS
-1.94
-1.87
-2.06
-1.76
-12.61
Diluted EPS
-1.94
-1.87
-2.06
-1.76
-12.61
Basic average shares
411,466
411,530
410,093
399,749
131,901
Diluted average shares
411,466
411,530
410,093
399,749
131,901